financetom
Business
financetom
/
Business
/
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
Nov 5, 2024 10:30 AM

(Reuters) -Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial officer, Bloomberg News reported on Tuesday citing one person familiar with the matter.

The company's president Stephen Hoge will take charge of sales as well as medical and research affairs, according to the report.

Bancel will remain in his role as Moderna's CEO, the report added. Moderna did not immediately respond to a Reuters request for comment.

Moderna had announced in December Bancel would head sales and marketing, and work directly with the company's commercial team, after then commercial officer Arpa Garay had decided to leave.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jan 13, 2025
03:30 PM EST, 01/13/2025 (MT Newswires) -- Consumer stocks were higher late Monday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) edging up 0.1%. In corporate news, Toyota ( TM ) has decided that North American salaried workers will return to the office Monday through Thursday, Bloomberg...
Potbelly Expects Q4 Same-Store Sales Growth Above Guidance; Shares Gain
Potbelly Expects Q4 Same-Store Sales Growth Above Guidance; Shares Gain
Jan 13, 2025
03:40 PM EST, 01/13/2025 (MT Newswires) -- Shares of Potbelly (PBPB) were up Monday after the sandwich shop chain reported preliminary Q4 results and said it expects Q4 same-store sales growth to top its prior outlook. For comparable company-operated stores open for at least 15 months, the company said it expects Q4 same-store sales growth of 0.2% to 0.3% year-over-year,...
MARA Holdings Unusual Options Activity
MARA Holdings Unusual Options Activity
Jan 13, 2025
Investors with a lot of money to spend have taken a bullish stance on MARA Holdings ( MARA ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Accuray Receives Chinese Approval for Radiation Therapy System, Radiosurgery Device
Accuray Receives Chinese Approval for Radiation Therapy System, Radiosurgery Device
Jan 13, 2025
03:38 PM EST, 01/13/2025 (MT Newswires) -- Accuray ( ARAY ) said Monday that it received approval from the Chinese National Medical Products Administration for its Radixact SynC and CyberKnife S7 System. Radixact SynC is a radiation therapy system designed to deliver precise and personalized treatment to patients with cancer and CyberKnife S7 is a robotic radiosurgery device for treating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved